Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Calpain cleaves phospholipid flippase ATP8A1 during apoptosis in platelets

dc.contributor.authorJing, Weidong
dc.contributor.authorYabas, Mehmet
dc.contributor.authorBröer, Angelika
dc.contributor.authorCoupland, Lucy
dc.contributor.authorGardiner, Elizabeth
dc.contributor.authorEnders, Anselm
dc.contributor.authorBroer, Stefan
dc.date.accessioned2021-01-11T04:20:43Z
dc.date.available2021-01-11T04:20:43Z
dc.date.issued2019
dc.description.abstractThe asymmetric distribution of phospholipids in the plasma/organellar membranes is generated and maintained through phospholipid flippases in resting cells, but becomes disrupted in apoptotic cells and activated platelets, resulting in phosphatidylserine (PS) exposure on the cell surface. Stable PS exposure during apoptosis requires inactivation of flippases to prevent PS from being reinternalized. Here we show that flippase ATP8A1 is highly expressed in both murine and human platelets, but is not present in the plasma membrane. ATP8A1 is cleaved by the cysteine protease calpain during apoptosis, and the cleavage is prevented indirectly by caspase inhibition, involving blockage of calcium influx into platelets and subsequent calpain activation. In contrast, in platelets activated with thrombin and collagen and exposing PS, ATP8A1 remains intact. These data reveal a novel mechanism of flippase cleavage and suggest that flippase activity in intracellular membranes differs between platelets undergoing apoptosis and activation.en_AU
dc.description.sponsorshipThis work was supported by National Health and Medical Research Council Grants (S.B., A.E., and E.E.G.) and by an Australian Government Research Training Program Scholarship (W.J.).en_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn2473-9529en_AU
dc.identifier.urihttp://hdl.handle.net/1885/219273
dc.language.isoen_AUen_AU
dc.provenancehttps://v2.sherpa.ac.uk/id/publication/32010..."The Published Version can be archived in a Non-Commercial Institutional Repository" from SHERPA/RoMEO site (as at 11/01/2021). © Blood Advances Online by the American Society of Hematologyen_AU
dc.publisherAmerican Society of Hematologyen_AU
dc.rights© 2019 by The American Society of Hematologyen_AU
dc.sourceBlood advancesen_AU
dc.subjectadenosine triphosphatasesen_AU
dc.subjectanimalsen_AU
dc.subjectapoptosisen_AU
dc.subjectblood plateletsen_AU
dc.subjectcalpainen_AU
dc.subjecthumansen_AU
dc.subjectmaleen_AU
dc.subjectmiceen_AU
dc.subjectmice, inbred c57blen_AU
dc.subjectphospholipid transfer proteinsen_AU
dc.subjectphospholipidsen_AU
dc.subjectplatelet activationen_AU
dc.titleCalpain cleaves phospholipid flippase ATP8A1 during apoptosis in plateletsen_AU
dc.typeJournal articleen_AU
dcterms.accessRightsOpen Accessen_AU
local.bibliographicCitation.issue3en_AU
local.bibliographicCitation.lastpage229en_AU
local.bibliographicCitation.startpage219en_AU
local.contributor.affiliationJing, Weidong, Division of Biomedical Science and Biochemistry, Research School of Biology, The Australian National Universityen_AU
local.contributor.affiliationYabas, M., Division of Biomedical Science and Biochemistry, Research School of Biology, The Australian National Universityen_AU
local.contributor.affiliationBröer, A., Division of Biomedical Science and Biochemistry, Research School of Biology, The Australian National Universityen_AU
local.contributor.affiliationCoupland, L., ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National Universityen_AU
local.contributor.affiliationGardiner, E., ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National Universityen_AU
local.contributor.affiliationEnders, A., John Curtin School of Medical Research, The Australian National Universityen_AU
local.contributor.affiliationBröer, S., Division of Biomedical Science and Biochemistry, Research School of Biology, The Australian National Universityen_AU
local.contributor.authoruidu4265664en_AU
local.identifier.citationvolume3en_AU
local.identifier.doi10.1182/bloodadvances.2018023473en_AU
local.identifier.essn2473-9537en_AU
local.publisher.urlhttps://ashpublications.org/bloodadvancesen_AU
local.type.statusSubmitted Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Blood Adv 2019 Jing.pdf
Size:
1.51 MB
Format:
Adobe Portable Document Format
Description:
Journal Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
884 B
Format:
Item-specific license agreed upon to submission
Description: